Pancreatic Cancer Research

ResearcherOslo University HospitalNo recent work listed

Trond A Buanes

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5014470340. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 3 papers · 2014: 1 paper · 2015: none · 2016: 4 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper

Papers 15

  1. Psychometric performance of the PAncreatic CAncer disease impact (PACADI) score. Last author DOI 10.1016/j.pan.2019.09.001↗
  2. Long term oncological outcome of laparoscopic techniques in pancreatic cancer. Co-author DOI 10.4253/wjge.v10.i12.383↗
  3. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection. Co-author DOI 10.1016/j.surg.2017.06.009↗
  4. Role of surgery in pancreatic cancer. Co-author DOI 10.3748/wjg.v23.i21.3765↗
  5. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: results of a multicenter cohort study on 196 patients. Co-author DOI 10.1007/s00464-015-4623-x↗
  6. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2015.09.004↗
  7. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first … Co-author DOI 10.3109/0284186x.2015.1068445↗
  8. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research. Co-author DOI 10.3748/wjg.v22.i48.10502↗
  9. Pancreatic cancer-improved care achievable. Co-author DOI 10.3748/wjg.v20.i30.10405↗
  10. Development and preliminary validation of the pancreatic cancer disease impact score. Last author DOI 10.1007/s00520-012-1713-3↗
  11. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Co-author DOI 10.1016/j.ejso.2013.02.020↗
  12. Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenoca… Last author DOI 10.1016/j.pan.2013.01.003↗
  13. The prognosis for pancreatic cancer patients--better than feared. Co-author DOI 10.4045/tidsskr.11.1242↗
  14. Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras. Last author DOI 10.1002/ijc.25449↗
  15. Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer. Co-author DOI 10.3109/13813455.2011.560609↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Knut Jørgen Labori · 7 shared papers, 2011–2017 · strength 0.35
  2. Bjørn Edwin · 4 shared papers, 2016–2018 · strength 0.34
  3. Turid Heiberg · 4 shared papers, 2013–2019 · strength 0.29
  4. Bart M.G. Baekelandt · 2 shared papers, 2016–2019 · strength 0.20
  5. Tom Nordby · 4 shared papers, 2013–2016 · strength 0.20
  6. Mushegh А. Sahakyan · 2 shared papers, 2016–2017 · strength 0.12
  7. Song Cheol Kim · 2 shared papers, 2016–2017 · strength 0.12
  8. Elin Hegland Kure · 2 shared papers, 2016 · strength 0.12
  9. Ivar P. Gladhaug · 2 shared papers, 2011–2016 · strength 0.08
  10. Ki Byung Song · 1 shared paper, 2017 · strength 0.07
  11. Dyre Berg Kleive · 1 shared paper, 2017 · strength 0.07
  12. Marianne Jensen Hjermstad · 1 shared paper, 2016 · strength 0.06
  13. Matthew H. G. Katz · 1 shared paper, 2016 · strength 0.05
  14. Svein Dueland · 1 shared paper, 2016 · strength 0.05
  15. Mohammad Abu Hilal · 1 shared paper, 2016 · strength 0.05
  16. Harald Hugenschmidt · 1 shared paper, 2013 · strength 0.04
  17. Fred Haugen · 1 shared paper, 2011 · strength 0.03
  18. Christian Andre Drevon · 1 shared paper, 2011 · strength 0.03
  19. Synne Wedén · 1 shared paper, 2011 · strength 0.03
  20. Gustav Gaudernack · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.